Serbousek Thomas R MD is categorized under Home Health Care Services in Anamosa, IA and active since 1994.
Serbousek Thomas R MD was established in 1994, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Home Health Care Services business, which does work in the B2C market, and is classified as a Home Health Care Services, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Thomas Serbousek at the company’s single location by writing to 104 Broadway Place, Anamosa, Iowa IA 52205 or by phoning (319) 462-6131. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Serbousek Thomas R MD |
| Contact Person: | Thomas Serbousek |
| Address: | 104 Broadway Place, Anamosa, Iowa 52205 |
| Phone Number: | (319) 462-6131 |
| Website Address: | jonesregional.org |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1994 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Home Health Care Services |
| SIC Code: | 8082 |
| NAICS Code: | 6211110 |
| Share This Business: |
Serbousek Thomas R MD was started in 1994 to provide professional Home Health Care Services under the SIC code 8082 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Thomas Serbousek for inquiries that concern Serbousek Thomas R MD by calling the company number (319) 462-6131, as your correspondence is most welcome. Additionally, the physical location of the single location of Serbousek Thomas R MD can be found at the coordinates 42.113193,-91.287438 as well as the street address 104 Broadway Place in Anamosa, Iowa 52205.
For its online presence, you may visit Serbousek Thomas R MD’s website at jonesregional.org and engage with its social media outlets through on Twitter and on Facebook.